Roeland Nusse insider trades: BIO-TECHNE (TECH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Roeland reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 25, 2025 | TECH | ↓ Sell | 17,040 | $56.36 | $960K | Direct | Aug 27, 2025 (2d) |
| Mar 7, 2024 | TECH | ↓ Sell | 10,400 | $76.98 | $801K | Direct | Mar 11, 2024 (4d) |
| Aug 30, 2023 | TECH | ↓ Sell | 8,939 | $80.32 | $718K | Direct | Sep 1, 2023 (2d) |
| Aug 23, 2021 | TECH | ↓ Sell | 4,000 | $481.52 | $1.9M | Direct | Aug 25, 2021 (2d) |
| Feb 8, 2021 | TECH | ↓ Sell | 6,000 | $385.08 | $2.3M | Direct | Feb 10, 2021 (2d) |
| Nov 25, 2019 | TECH | ↓ Sell | 8,347 | $219.33 | $1.8M | Direct | Nov 29, 2019 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TECH insiders
Open-market trades in the last 12 months
About Roeland Nusse's insider trades
Roeland Nusse is a director at BIO-TECHNE (TECH). Since Nov 25, 2019, Roeland has reported no open-market purchases and 6 sales worth $8.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), option exercises (5 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TECH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.